Enabling Treatment for Genetic Diseases
A team of researchers from GIS developed a CRISPR-based gene editor, C-to-G Base Editor (CGBE), to correct mutations that cause genetic disorders. This invention opens up treatment options for human diseases such as cystic fibrosis, cardiovascular diseases, musculoskeletal diseases and neurological disorders. This research has been published in Nature Communications.
The C-to-G base editor (CGBE) converts C in genes to G. This invention corrects disease-causing mutations into healthy versions, enabling treatment for genetic diseases.
A*STAR celebrates International Women's Day
From groundbreaking discoveries to cutting-edge research, our researchers are empowering the next generation of female science, technology, engineering and mathematics (STEM) leaders.
Get inspired by our #WomeninSTEM